Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation. [electronic resource]
Producer: 20090710Description: 445-55 p. digitalISSN:- 1479-6805
- Activins -- pharmacology
- Blotting, Western
- Bone Morphogenetic Protein 2 -- pharmacology
- Bone Morphogenetic Protein 4 -- pharmacology
- Bone Morphogenetic Protein 6 -- pharmacology
- Bone Morphogenetic Protein 7 -- pharmacology
- Bone Morphogenetic Protein Receptors, Type I -- genetics
- Bone Morphogenetic Protein Receptors, Type II -- genetics
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Electrophoresis, Polyacrylamide Gel
- Enzyme Activation -- drug effects
- Estradiol -- pharmacology
- Estrogen Receptor alpha -- genetics
- Estrogen Receptor beta -- genetics
- Estrogens -- pharmacology
- Follistatin -- genetics
- Humans
- Microscopy, Fluorescence
- Mitosis -- drug effects
- Oligonucleotide Array Sequence Analysis
- Receptors, Estrogen -- genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Steryl-Sulfatase -- genetics
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.